UNSPSC 51131700: Thrombolytic drugs and platelet aggregation inhibitors

This classification denotes drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.

UNSPSC 51131700 Thrombolytic drugs and platelet aggregation inhibitors is a Class code that shows no relevant recent state and local procurement activity. The single opportunity tagged to this code—Sourcewell RFP #061626 posted May 12, 2026, with response due June 16, 2026—solicits law enforcement equipment for a multi-state cooperative purchasing vehicle, a scope wholly unrelated to pharmaceutical products. The code's nominal scope covers medications used in emergency cardiac and stroke care, but the recent-opportunities record does not support active state or local buying in this category.

No geographic concentration, issuing-body pattern, or representative pharmaceutical procurement can be inferred from the available source material. Firms evaluating this code should confirm whether state and local health departments, emergency medical services procurement offices, hospitals within municipal or county systems, or correctional health services are actively sourcing thrombolytic or antiplatelet drugs through formal solicitations, as the indexed data does not reflect current market activity under this classification.